Pfizer Covered Up Vaccine Trial Deaths to Secure Authorization for Public Use

Pfizer covered up a staggering 80 percent of deaths that were recorded during Big Pharma company’s mRNA vaccine trials in an effort to secure authorization for public use from federal regulators.

A bombshell new study has revealed that Pfizer-BioNTech was aware of a huge spike in deaths that occurred during the trials but held back the information from the U.S. Food and Drug Administration (FDA).

The Big Pharma company reportedly delayed reporting vaccine-associated deaths among BNT162b2 clinical trial participants until after the FDA issued an Emergency Use Authorization (EUA) for the mass public use of the product.

According to analysis in the International Journal of Vaccine Theory, Practice, and Research, Pfizer also failed to account for vast numbers of participants who dropped out of the drug trials.

Experts are now raising the alarm about the discovery these strategies kept regulators and the public in the dark about a 3.7-fold increase in cardiac deaths among subjects who received the vaccine.

The authors of the paper described it as a “forensic analysis,” defined by the U.S. National Institute for Standards and Technology as “the use of scientific methods or expertise to investigate crimes or examine evidence that might be presented in a court of law.”

The Pfizer/BioNTech Documents



Subscribe to Our Free Newsletter